Dargan PI, Button J, Davies S, Ramsey J, George S, Holt DW, Wood DM.
The first reported UK fatality related to gamma-butyrolactone (GBL) ingestion. J R Soc Med. 2009 Dec;102(12):546-7.
Wood DM, Looker JJ, Shaikh L, Button J, Puchnarewicz M, Davies S, Lidder S, Ramsey J, Holt DW, Dargan PI.
Delayed onset of seizures and toxicity associated with recreational use of Bromo-dragonFLY. J Med Toxicol. 2009 Dec;5(4):226-9.
Ng FL, Holt DW, Chang RW, Macphee IA.
Black renal transplant recipients have poorer long-term graft survival than CYP3A5 expressers from other ethnic groups. Nephrol Dial Transplant. 2010 Feb;25(2):628-34.
Morrison PD, Zois V, McKeown DA, Lee TD, Holt DW, Powell JF, Kapur S, Murray RM.
The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning. Psychol Med. 2009 Oct;39(10):1607-16.
Kirwan CJ, Lee T, Holt DW, Grounds RM, MacPhee IA, Philips BJ.
Using midazolam to monitor changes in hepatic drug metabolism in critically ill patients. Intensive Care Med. 2009 Jul;35(7):1271-5.
Wallemacq P, Armstrong VW, Brunet M, Haufroid V, Holt DW, Johnston A, Kuypers D, Le Meur Y, Marquet P, Oellerich M, Thervet E, Toenshoff B, Undre N, Weber LT, Westley IS, Mourad M.
Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Ther Drug Monit. 2009 Apr;31(2):139-52.
Kiechl S, Lee T, Santer P, Thompson G, Tsimikas S, Egger G, Holt DW, Willeit J, Xu Q, Mayr M.
Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general population. Atherosclerosis. 2009 Jul;205(1):261-5.
Ovaska H, Viljoen A, Puchnarewicz M, Button J, Ramsey J, Holt DW, Dargan PI, Wood DM.
First case report of recreational use of 2,5-dimethoxy-4-chloroamphetamine confirmed by toxicological screening. Eur J Emerg Med. 2008 Dec;15(6):354-6.
Wood DM, Button J, Lidder S, Ramsey J, Holt DW, Dargan PI.
Dissociative and sympathomimetic toxicity associated with recreational use of 1-(3-trifluoromethylphenyl) piperazine (TFMPP) and 1-benzylpiperzine (BZP). J Med Toxicol. 2008 Dec;4(4):254-7.
van Gelder T, Silva HT, de Fijter JW, Budde K, Kuypers D, Tyden G, Lohmus A, Sommerer C, Hartmann A, Le Meur Y, Oellerich M, Holt DW, Tönshoff B, Keown P, Campbell S, Mamelok RD.
Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial. Transplantation. 2008 Oct 27;86(8):1043-51.
The first reported UK fatality related to gamma-butyrolactone (GBL) ingestion. J R Soc Med. 2009 Dec;102(12):546-7.
Wood DM, Looker JJ, Shaikh L, Button J, Puchnarewicz M, Davies S, Lidder S, Ramsey J, Holt DW, Dargan PI.
Delayed onset of seizures and toxicity associated with recreational use of Bromo-dragonFLY. J Med Toxicol. 2009 Dec;5(4):226-9.
Ng FL, Holt DW, Chang RW, Macphee IA.
Black renal transplant recipients have poorer long-term graft survival than CYP3A5 expressers from other ethnic groups. Nephrol Dial Transplant. 2010 Feb;25(2):628-34.
Morrison PD, Zois V, McKeown DA, Lee TD, Holt DW, Powell JF, Kapur S, Murray RM.
The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning. Psychol Med. 2009 Oct;39(10):1607-16.
Kirwan CJ, Lee T, Holt DW, Grounds RM, MacPhee IA, Philips BJ.
Using midazolam to monitor changes in hepatic drug metabolism in critically ill patients. Intensive Care Med. 2009 Jul;35(7):1271-5.
Wallemacq P, Armstrong VW, Brunet M, Haufroid V, Holt DW, Johnston A, Kuypers D, Le Meur Y, Marquet P, Oellerich M, Thervet E, Toenshoff B, Undre N, Weber LT, Westley IS, Mourad M.
Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Ther Drug Monit. 2009 Apr;31(2):139-52.
Kiechl S, Lee T, Santer P, Thompson G, Tsimikas S, Egger G, Holt DW, Willeit J, Xu Q, Mayr M.
Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general population. Atherosclerosis. 2009 Jul;205(1):261-5.
Ovaska H, Viljoen A, Puchnarewicz M, Button J, Ramsey J, Holt DW, Dargan PI, Wood DM.
First case report of recreational use of 2,5-dimethoxy-4-chloroamphetamine confirmed by toxicological screening. Eur J Emerg Med. 2008 Dec;15(6):354-6.
Wood DM, Button J, Lidder S, Ramsey J, Holt DW, Dargan PI.
Dissociative and sympathomimetic toxicity associated with recreational use of 1-(3-trifluoromethylphenyl) piperazine (TFMPP) and 1-benzylpiperzine (BZP). J Med Toxicol. 2008 Dec;4(4):254-7.
van Gelder T, Silva HT, de Fijter JW, Budde K, Kuypers D, Tyden G, Lohmus A, Sommerer C, Hartmann A, Le Meur Y, Oellerich M, Holt DW, Tönshoff B, Keown P, Campbell S, Mamelok RD.
Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial. Transplantation. 2008 Oct 27;86(8):1043-51.
Bioanalytics and Forensic Toxicology
